{"id":"https://openalex.org/W7224818719","doi":"https://doi.org/10.59324/ejmhr.2026.4(6).02","title":"Patient Preferences and Quality-of-Life Changes after Switching from Intravenous to Subcutaneous Trastuzumab in HER2-Positive Breast Cancer: A Prospective Observational Study","display_name":"Patient Preferences and Quality-of-Life Changes after Switching from Intravenous to Subcutaneous Trastuzumab in HER2-Positive Breast Cancer: A Prospective Observational Study","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224818719","doi":"https://doi.org/10.59324/ejmhr.2026.4(6).02"},"language":"en","primary_location":{"id":"doi:10.59324/ejmhr.2026.4(6).02","doi":"https://doi.org/10.59324/ejmhr.2026.4(6).02","is_oa":true,"landing_page_url":"https://doi.org/10.59324/ejmhr.2026.4(6).02","pdf_url":null,"source":{"id":"https://openalex.org/S4387292043","display_name":"European Journal of Medical and Health Research","issn_l":"2786-8524","issn":["2786-8524"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medical and Health Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.59324/ejmhr.2026.4(6).02","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120442251","display_name":"Adnane Adnani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]},{"id":"https://openalex.org/I99297268","display_name":"University of Hassan II Casablanca","ror":"https://ror.org/001q4kn48","country_code":"MA","type":"education","lineage":["https://openalex.org/I99297268"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"Adnane Adnani","raw_affiliation_strings":["Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210138534","https://openalex.org/I99297268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120492684","display_name":"Latifa Doublali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]},{"id":"https://openalex.org/I99297268","display_name":"University of Hassan II Casablanca","ror":"https://ror.org/001q4kn48","country_code":"MA","type":"education","lineage":["https://openalex.org/I99297268"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"Latifa Doublali","raw_affiliation_strings":["Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210138534","https://openalex.org/I99297268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033443344","display_name":"Mouna Bourhafour","orcid":"https://orcid.org/0000-0001-7975-9172","observed_orcids":["https://orcid.org/0000-0001-7975-9172"]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]},{"id":"https://openalex.org/I99297268","display_name":"University of Hassan II Casablanca","ror":"https://ror.org/001q4kn48","country_code":"MA","type":"education","lineage":["https://openalex.org/I99297268"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"Mouna Bourhafour","raw_affiliation_strings":["Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210138534","https://openalex.org/I99297268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047504108","display_name":"Karima Bendahhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"Karima Bendahhou","raw_affiliation_strings":["Department of Epidemiology and Public Health, Casablanca Cancer Registry, Ibn Rochd University Hospital, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Public Health, Casablanca Cancer Registry, Ibn Rochd University Hospital, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210138534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034870219","display_name":"Meryem Belhouari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]},{"id":"https://openalex.org/I99297268","display_name":"University of Hassan II Casablanca","ror":"https://ror.org/001q4kn48","country_code":"MA","type":"education","lineage":["https://openalex.org/I99297268"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"Meryem Belhouari","raw_affiliation_strings":["Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210138534","https://openalex.org/I99297268"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088782205","display_name":"S. Sahraoui","orcid":"https://orcid.org/0000-0003-1169-3087","observed_orcids":["https://orcid.org/0000-0003-1169-3087"]},"institutions":[{"id":"https://openalex.org/I4210138534","display_name":"Centre Hospitalier Universitaire Ibn Rochd","ror":"https://ror.org/03sbc8x80","country_code":"MA","type":"healthcare","lineage":["https://openalex.org/I4210138534"]},{"id":"https://openalex.org/I99297268","display_name":"University of Hassan II Casablanca","ror":"https://ror.org/001q4kn48","country_code":"MA","type":"education","lineage":["https://openalex.org/I99297268"]}],"countries":["MA"],"is_corresponding":false,"raw_author_name":"Souha Sahraoui","raw_affiliation_strings":["Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mohammed VI Center for Cancer Treatment, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco","institution_ids":["https://openalex.org/I4210138534","https://openalex.org/I99297268"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82171544,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"6","first_page":"6","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.07800000160932541,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.04320000112056732,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8849999904632568},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9580000042915344},{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.9679999947547913},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9700000286102295},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9789999723434448},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.6740000247955322},{"id":"https://openalex.org/keywords/injection-site-pain","display_name":"injection site pain","score":0.972000002861023},{"id":"https://openalex.org/keywords/eortc-qlq-c30","display_name":"EORTC QLQ-C30","score":0.8640000224113464},{"id":"https://openalex.org/keywords/eortc-qlq-br23","display_name":"EORTC QLQ-BR23","score":0.9259999990463257},{"id":"https://openalex.org/keywords/treatment-side-effects","display_name":"treatment side effects","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9354000091552734},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.8019999861717224},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.621999979019165},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.5751000046730042},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5379999876022339},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5306000113487244},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.49889999628067017},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.48410001397132874},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.44130000472068787},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.4066999852657318},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.39989998936653137},{"id":"https://openalex.org/C2776093070","wikidata":"https://www.wikidata.org/wiki/Q621636","display_name":"Route of administration","level":2,"score":0.3698999881744385},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.36419999599456787},{"id":"https://openalex.org/C2992669165","wikidata":"https://www.wikidata.org/wiki/Q1131635","display_name":"Pain score","level":2,"score":0.3237999975681305},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3156000077724457},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.31220000982284546},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2833999991416931},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.27160000801086426},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2709999978542328},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.2623000144958496},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2596000134944916},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2567000091075897}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.59324/ejmhr.2026.4(6).02","doi":"https://doi.org/10.59324/ejmhr.2026.4(6).02","is_oa":true,"landing_page_url":"https://doi.org/10.59324/ejmhr.2026.4(6).02","pdf_url":null,"source":{"id":"https://openalex.org/S4387292043","display_name":"European Journal of Medical and Health Research","issn_l":"2786-8524","issn":["2786-8524"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medical and Health Research","raw_type":"journal-article"},{"id":"pmh:oai:HAL:hal-05843612v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-05843612","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Medical and Health Research, 2026, 4 (6), pp.6-13. &#x27E8;10.59324/ejmhr.2026.4(6).02&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.59324/ejmhr.2026.4(6).02","doi":"https://doi.org/10.59324/ejmhr.2026.4(6).02","is_oa":true,"landing_page_url":"https://doi.org/10.59324/ejmhr.2026.4(6).02","pdf_url":null,"source":{"id":"https://openalex.org/S4387292043","display_name":"European Journal of Medical and Health Research","issn_l":"2786-8524","issn":["2786-8524"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medical and Health Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2418173743","https://openalex.org/W2593243200","https://openalex.org/W3038002369","https://openalex.org/W2024903800","https://openalex.org/W4301595073","https://openalex.org/W2943252354","https://openalex.org/W2688564736","https://openalex.org/W2593947930","https://openalex.org/W1549851394","https://openalex.org/W2335028181"],"abstract_inverted_index":{"Background:":[0],"Patient":[1,212],"preferences":[2,77,213],"and":[3,50,63,73,119,149,151,159,161,189,203,214],"health-related":[4],"quality":[5],"of":[6,11,54,179],"life":[7,55],"are":[8],"complementary":[9,219],"measures":[10],"treatment":[12,120],"experience.":[13],"We":[14],"assessed":[15,57,79],"these":[16],"outcomes":[17],"among":[18,181],"women":[19,43],"with":[20,91],"HER2-positive":[21],"breast":[22],"cancer":[23],"transitioning":[24],"from":[25,135],"intravenous":[26,106],"to":[27,137,207],"subcutaneous":[28,61,128,197],"trastuzumab":[29],"in":[30,34,44],"routine":[31],"clinical":[32],"practice":[33],"Morocco.":[35],"Methods:":[36],"This":[37],"prospective":[38],"observational":[39],"study":[40],"enrolled":[41],"150":[42],"Casablanca,":[45],"Morocco,":[46],"between":[47],"June":[48],"2023":[49],"April":[51],"2024.":[52],"Quality":[53],"was":[56,100,175],"before":[58],"the":[59,123,208],"first":[60],"injection":[62],"after":[64],"eight":[65],"injections":[66],"using":[67,80,88],"validated":[68],"Moroccan":[69],"Arabic":[70],"EORTC":[71],"QLQ-C30":[72],"QLQ-BR23":[74],"questionnaires.":[75],"Administration":[76],"were":[78,86,122,201],"a":[81],"separate":[82],"questionnaire.":[83],"Score":[84],"changes":[85,200],"analyzed":[87],"paired":[89],"t-tests":[90],"Holm":[92],"adjustment":[93],"across":[94],"23":[95],"domains.":[96],"Results:":[97],"Subcutaneous":[98],"administration":[99,107,209,223],"preferred":[101,196],"by":[102,108,177],"133":[103],"patients":[104,195],"(88.7%),":[105],"8":[109],"(5.3%),":[110],"while":[111],"9":[112],"(6%)":[113],"reported":[114,176],"no":[115],"preference.":[116],"Time":[117],"saving":[118],"simplicity":[121],"main":[124],"reasons":[125],"for":[126],"preferring":[127],"administration.":[129],"Mean":[130],"global":[131],"health":[132],"status":[133],"increased":[134,167],"37.1":[136],"68.9":[138],"(mean":[139],"change,":[140],"31.8":[141],"points;":[142],"95%":[143],"CI,":[144],"28.3\u201335.4).":[145],"Emotional":[146],"functioning":[147,157],"improved":[148],"pain":[150,174],"fatigue":[152],"scores":[153,166],"decreased,":[154],"whereas":[155],"physical":[156],"declined":[158],"diarrhea":[160],"systemic":[162],"therapy":[163],"side":[164],"effect":[165],"(all":[168],"Holm-adjusted":[169],"P":[170],"<":[171],"0.001).":[172],"Injection-site":[173],"48%":[178],"patients;":[180],"those":[182],"affected,":[183],"70%":[184],"described":[185],"it":[186],"as":[187,191],"mild":[188],"87%":[190],"brief.":[192],"Conclusion:":[193],"Most":[194],"trastuzumab.":[198],"Quality-of-life":[199],"heterogeneous":[202],"cannot":[204],"be":[205],"attributed":[206],"route":[210],"alone.":[211],"domain-specific":[215],"quality-of-life":[216],"assessments":[217],"provide":[218],"information":[220],"when":[221],"discussing":[222],"options.":[224]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-31T00:00:00"}